Summary:

“Salesforce Research collaborated with the Ellison Institute to develop ReceptorNet, a deep-learning algorithm that can determine hormone-receptor status – a crucial biomarker for clinicians when deciding on the appropriate treatment path for breast cancer patients — with excellent sensitivity and specificity numbers.”

Article written by  Salesforce

11|12|2020

Source:

EurekAlert

https://www.eurekalert.org/pub_releases/2020-12/s-hac120920.php

Pin It on Pinterest